Ozempic

Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management, developed by Novo Nordisk in 2012.Semaglutide is a GLP-1 receptor agonist, meaning that it mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control.

Read more in the app

Drugs Like Ozempic May Have a Shrinking Effect on The Heart

Could Ozempic be our next tool in fighting the overdose crisis? Surprising research suggests so

Ozempic and Wegovy may help curb alcohol addiction, study suggests

Experts Are Concerned Drugs Like Ozempic May Cause Muscle Loss

Ozempic Gives Strong Relief to Severe Knee Pain, Clinical Trial Suggests

Can Ozempic Treat Kidney Damage? Groundbreaking Study Uncovers Powerful New Benefits

Active ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's disease: Study

The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug

Scientists Discover Amazing New Benefit of Ozempic: Reducing Alcohol and Opioid Addiction

NASA’s Perseverance Rover Ascends, Ozempic Is Linked to Depression, and Mpox Cases Spread Rapidly

People Are Overdosing on Semaglutide Drugs like Ozempic and Wegovy

Ozempic and Wegovy could help people quit smoking

Combining Ayahuasca Compound with Drugs like Ozempic Could Help Treat Diabetes

What’s the Secret behind Ozempic’s Sweeping Health Benefits?

Tracking Ozempic’s Nausea Side Effect to Specific Neurons May Lead to Better Drugs

Study Shows One Drug Performs Better Than Ozempic For Weight Loss

No More Nausea: New Discovery Could Reduce the Side Effects of Ozempic and Wegovy

Some States Say They Can’t Afford Ozempic and Other Weight Loss Drugs

Stop criticising Ozempic - it could be a solution to more than obesity